Patanjali Research Foundation to study spike protein of Covid’s new JN.1 variant
This is the first time a study is being conducted on the spike protein of Covid's new JN.1 variant.
This is the first time a study is being conducted on the spike protein of Covid's new JN.1 variant.
"By building a skeleton of the spike, we could see how the spike is moving, and how this movement changes with mutations,"
"The Beta variant is somewhat resistant to the current vaccines, and we think a booster with the new genetic sequence can be beneficial for protecting against this variant,"
